Dr. Bryce studies cancer genetics and novel therapeutics with a focus on personalized medicine. His clinical practice centers on genitourinary malignancies (prostate, kidney, bladder, and testicular cancers) and melanoma.
As the Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona, Dr. Bryce utilizes whole genome sequencing of tumors to identify key driver mutations, leading to a greater chance of remission for patients. He also conducts Phase I clinical trials of new cancer drugs.